SEMAG is an advanced GLP-1 receptor agonist developed to support adults with type 2 diabetes in achieving better blood sugar control while offering an added benefit of weight management. This once-weekly injectable therapy mimics a natural hormone in the body to regulate insulin secretion, reduce appetite, and slow gastric emptying.

